IRISH STOCK EXCHANGE ANNOUNCEMENT
For Immediate Release
8 May 2017
HIKMA PHARMACEUTICALS PLC
(the "Issuer")
With effect from 3 May 2017 the registered address of the Issuer has changed to the following address:
1 New Burlington Place
London
United Kingdom
W1S 2HR
Enquiries: Peter Speirs (Company Secretary), +44 (0)207 3992772
This announcement has been issued through the Companies Announcement Service of
the Irish Stock Exchange.
